Auna S.A.

NYSE:AUNA Rapport sur les actions

Capitalisation boursière : US$388.6m

Auna Croissance future

Future contrôle des critères 3/6

Auna devrait augmenter ses bénéfices et son chiffre d'affaires de 32% et de 5.7% par an respectivement. Le BPA devrait croître de de 31.3% par an. Le rendement des capitaux propres devrait être 13.5% dans 3 ans.

Informations clés

32.0%

Taux de croissance des bénéfices

31.25%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.7%
Taux de croissance des recettes5.7%
Rendement futur des capitaux propres13.55%
Couverture par les analystes

Good

Dernière mise à jour05 Jun 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • Jun 29

AUNA: Lowered Price View And 2026 Guidance Will Frame Execution Risks

Analysts have reduced their price target on Auna to $5 from $6, citing lowered estimates following a worse-than-expected Q1 report. What’s in the News for Auna Auna reaffirmed its earnings guidance for 2026, indicating that its full-year outlook for that period remains unchanged.
Mise à jour du récit • Jun 15

AUNA: Reaffirmed 2026 Guidance Will Challenge Bearish Reset After Q1 Setback

Analysts have trimmed their view on Auna, with the consensus price target moving down by $1 to $5, citing weaker than expected Q1 results and lower company estimates. What's in the News Auna reaffirmed earnings guidance for 2026, maintaining its outlook for the full year.
Mise à jour du récit • Jun 01

AUNA: Mexico Execution And 2026 Guidance Will Drive Bullish Re Rating

Analysts have reduced their price target on Auna by $1 to $5, reflecting updated assumptions for fair value, discount rate, growth, margins, and future P/E following a worse than expected Q1 report. What's in the News Auna issued new earnings guidance for fiscal year 2026, projecting revenue growth of about 12% on a constant currency basis, within a range of 10% to 14%.
Seeking Alpha • May 29

Auna: A Discounted Hospital Operator With An Insurance Twist

Summary Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA’s leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging. With a P/FCF of 1.9x and P/E of 5x (2026E), AUNA offers material upside if operational and macro risks continue to abate. Read the full article on Seeking Alpha
Article d’analyse • May 28

Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings

Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...
Mise à jour du récit • May 04

AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset

Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.
Mise à jour du récit • Apr 19

AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating

Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.
Mise à jour du récit • Apr 05

AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside

Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.
Mise à jour du récit • Mar 22

AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook

Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.
Mise à jour du récit • Mar 08

AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential

Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.
Mise à jour du récit • Feb 22

AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside

Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.
Mise à jour du récit • Feb 07

AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential

Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.
Mise à jour du récit • Jan 24

AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential

Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.
Article d’analyse • Jan 23

Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Mise à jour du récit • Jan 10

AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks

Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.
Mise à jour du récit • Dec 22

AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential

Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.
Mise à jour du récit • Dec 08

AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential

Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.
Mise à jour du récit • Nov 24

AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential

Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.
Article d’analyse • Nov 14

Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
User avatar
Nouveau récit • May 29

High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape

Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.
Article d’analyse • Jan 29

A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb

The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...
Article d’analyse • Jan 19

Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Seeking Alpha • Jan 15

Auna: Cheap Entry Level In Latin American Healthcare Play

Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking Alpha

Prévisions de croissance des bénéfices et des revenus

NYSE:AUNA - Estimations futures des analystes et données financières antérieures (PEN Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20285,2443366507784
12/31/20275,0162806365977
12/31/20264,748227301417
3/31/20264,52169601731N/A
12/31/20254,38598518663N/A
9/30/20254,316187471633N/A
6/30/20254,325237481648N/A
3/31/20254,352159456620N/A
12/31/20244,386110527668N/A
9/30/20244,344-123473621N/A
6/30/20244,233-261418585N/A
3/31/20244,058-263419585N/A
12/31/20233,876-254417582N/A
9/30/20233,659-112392535N/A
6/30/20233,241-76310433N/A
3/31/20232,861-100231361N/A
12/31/20222,452-8611163N/A
9/30/20222,118-65-123123N/A
6/30/20222,009-64-108125N/A
3/31/20221,937-35-19093N/A
12/31/20211,924-26-106183N/A
9/30/20211,874208216N/A
6/30/20211,77942-26189N/A
3/31/20211,5775138180N/A
12/31/20201,444-727156N/A
9/30/20201,37328-12124N/A
6/30/20201,33514-11119N/A
3/31/20201,381163143N/A
12/31/20191,38373N/A152N/A
12/31/201886136N/A109N/A
12/31/201772322N/A96N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de AUNA ( 32% par an) est supérieure au taux d'épargne ( 3.5% ).

Bénéfices vs marché: Les bénéfices de AUNA ( 32% par an) devraient croître plus rapidement que le marché US ( 18.2% par an).

Croissance élevée des bénéfices: Les bénéfices de AUNA devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de AUNA ( 5.7% par an) devrait croître plus lentement que le marché de US ( 13% par an).

Croissance élevée des revenus: Le chiffre d'affaires de AUNA ( 5.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de AUNA devrait être faible dans 3 ans ( 13.5 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/07/14 21:23
Cours de l'action en fin de journée2026/07/14 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Auna S.A. est couverte par 7 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Samuel Campos AlvesBTG Pactual
Leandro BastosCitigroup Inc
Raj SinhaHSBC